In ₹ Crore except Per Share 12 Months Ending | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | |
|---|---|---|---|---|---|---|
| Other Income | 2.4 | 0.4 | 3.0 | 1.7 | 1.9 | |
| Revenue Detail — as filed | ||||||
| + Operating Income | 3,986.6 | 4,115.2 | 4,265.7 | 4,444.6 | 4,545.4 | |
| + Income from Investments (net) | 185.9 | 176.6 | 181.9 | 192.5 | 216.4 | |
| Expense Detail — as filed | ||||||
| + Employee Remuneration & Welfare | 458.1 | 394.7 | 441.0 | 518.8 | 628.8 | |
| + Commission (net) | 759.8 | 507.8 | 690.9 | 682.1 | 792.6 | |
| + Commission & Brokerage (net) | 759.8 | 507.8 | 690.9 | 682.1 | 792.6 | |
| + Non-operating Expense | 15.1 | 15.2 | 18.3 | 19.3 | 19.0 | |
| + Non-operating Provision — Doubtful Debts | 0.4 | 0.0 | 0.0 | 0.1 | 0.2 | |
| Profit Build-up — Alternate / Pre-Ind-AS Tags | ||||||
| Profit before Extraordinary Items | -0.9 | 352.0 | 77.7 | 173.4 | 151.2 | |
| Profit / (Loss) before Tax — alt tag | -0.9 | 352.0 | 77.7 | 173.4 | 151.2 | |
| + Provision for Tax | -1.4 | 89.5 | 22.8 | 45.2 | 39.9 | |
| Profit / (Loss) after Tax | 0.5 | 262.5 | 54.9 | 128.2 | 111.3 | |
| Profit Carried to Balance Sheet | 0.5 | 262.5 | 54.9 | 128.2 | 111.3 | |
| Per Share — as-filed variants | ||||||
| Basic & Diluted EPS before Extraordinary (not annualised) | 0.01 | 4.47 | 0.93 | 2.18 | 1.89 | |
| Basic & Diluted EPS after Extraordinary (not annualised) | 0.01 | 4.47 | 0.92 | 2.18 | 1.89 | |
| Appropriations & Transfers | ||||||
| + Transfer to Profit & Loss Account | -86.9 | 248.6 | -19.2 | 69.2 | 64.0 | |
| Reserves & Surplus excl. Revaluation Reserve | 6,435.9 | 6,698.6 | 6,755.4 | 6,889.6 | 7,000.8 | |
| Insurance — Revenue Account (Policyholders') | ||||||
| Premium Earned | 3,798.3 | 3,938.3 | 4,080.8 | 4,250.4 | 4,327.2 | |
| + Gross Premiums Written | 5,138.0 | 3,605.5 | 4,423.8 | 4,624.2 | 5,968.4 | |
| + Net Premium Written | 4,819.6 | 3,457.4 | 4,233.4 | 4,360.9 | 5,598.6 | |
| + Operating Expenses — Insurance Business | 683.6 | 619.7 | 676.4 | 779.9 | 883.9 | |
| + Non-operating Expenses — Non-insurance | 14.6 | 15.2 | 18.3 | 19.2 | 18.8 | |
| + Claims Paid | 2,654.6 | 2,763.4 | 2,827.7 | 3,055.2 | 2,640.6 | |
| + Incurred Claims | 2,630.1 | 2,739.0 | 2,917.6 | 2,913.5 | 2,805.0 | |
| + Change in Outstanding Claims | -24.5 | -24.3 | 90.0 | -141.7 | 164.4 | |
| Insurance — Shareholders' Account | ||||||
| + Income — Shareholders' Account | 14.2 | 367.2 | 96.0 | 192.7 | 170.2 | |
| + Shareholders' Investment Income | 97.0 | 118.0 | 115.0 | 123.4 | 104.6 | |
| + Transfer from Policyholders' Fund | -86.9 | 248.6 | -19.2 | 69.2 | 64.0 | |
| With Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Insurance — IRDAI Ratios (as filed, not percentages) | ||||||
| Solvency Ratio | 2.21 | 2.22 | 0.02 | 2.14 | 2.05 | |
| Combined Ratio | 0.99 | 1.02 | 1.04 | 1.02 | 0.95 | |
| Incurred Claim Ratio | 0.69 | 0.70 | 0.72 | 0.69 | 0.65 | |
| Net Retention Ratio | 0.94 | 0.96 | 0.96 | 0.94 | 0.94 | |
| Expenses of Management Ratio | 0.30 | 0.33 | 0.33 | 0.34 | 0.30 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | ||||||
| Investor Complaints — During the Period | -1.00 | -1.00 | 0.00 | 0.00 | 0.00 | |
| Investor Complaints — Disposed | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | |
| Related-party Transactions — During the Period | 7.5 | — | 5.2 | — | 6.8 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | ||||||
| Operating Expenses | 4,073.5 | 3,866.5 | 4,284.9 | 4,375.4 | 4,481.4 | |
| Other Operating Expenses | 225.5 | 225.0 | 235.4 | 261.1 | 255.1 | |